158 related articles for article (PubMed ID: 9818932)
1. Enhanced oxygen radical production in a transgenic mouse model of familial amyotrophic lateral sclerosis.
Liu R; Althaus JS; Ellerbrock BR; Becker DA; Gurney ME
Ann Neurol; 1998 Nov; 44(5):763-70. PubMed ID: 9818932
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic benefits of putrescine-modified catalase in a transgenic mouse model of familial amyotrophic lateral sclerosis.
Reinholz MM; Merkle CM; Poduslo JF
Exp Neurol; 1999 Sep; 159(1):204-16. PubMed ID: 10486188
[TBL] [Abstract][Full Text] [Related]
3. Partial deficiency of manganese superoxide dismutase exacerbates a transgenic mouse model of amyotrophic lateral sclerosis.
Andreassen OA; Ferrante RJ; Klivenyi P; Klein AM; Shinobu LA; Epstein CJ; Beal MF
Ann Neurol; 2000 Apr; 47(4):447-55. PubMed ID: 10762155
[TBL] [Abstract][Full Text] [Related]
4. Pathogenic mechanisms in familial amyotrophic lateral sclerosis due to mutation of Cu, Zn superoxide dismutase.
Gurney ME; Cutting FB; Zhai P; Andrus PK; Hall ED
Pathol Biol (Paris); 1996 Jan; 44(1):51-6. PubMed ID: 8734301
[TBL] [Abstract][Full Text] [Related]
5. Midbrain dopaminergic neuronal degeneration in a transgenic mouse model of familial amyotrophic lateral sclerosis.
Kostic V; Gurney ME; Deng HX; Siddique T; Epstein CJ; Przedborski S
Ann Neurol; 1997 Apr; 41(4):497-504. PubMed ID: 9124807
[TBL] [Abstract][Full Text] [Related]
6. [Amyotrophic lateral sclerosis: recent insights from transgenic animal models with SOD1 mutations].
Aoki M
Rinsho Shinkeigaku; 2004 Nov; 44(11):788-91. PubMed ID: 15651292
[TBL] [Abstract][Full Text] [Related]
7. Transgenics, toxicity and therapeutics in rodent models of mutant SOD1-mediated familial ALS.
Turner BJ; Talbot K
Prog Neurobiol; 2008 May; 85(1):94-134. PubMed ID: 18282652
[TBL] [Abstract][Full Text] [Related]
8. Stabilization of mutant Cu/Zn superoxide dismutase (SOD1) protein by coexpressed wild SOD1 protein accelerates the disease progression in familial amyotrophic lateral sclerosis mice.
Fukada K; Nagano S; Satoh M; Tohyama C; Nakanishi T; Shimizu A; Yanagihara T; Sakoda S
Eur J Neurosci; 2001 Dec; 14(12):2032-6. PubMed ID: 11860498
[TBL] [Abstract][Full Text] [Related]
9. Expression of the copper-zinc superoxide dismutase gene in amyotrophic lateral sclerosis.
Nishiyama K; Murayama S; Kwak S; Kanazawa I
Ann Neurol; 1997 Apr; 41(4):551-6. PubMed ID: 9124814
[TBL] [Abstract][Full Text] [Related]
10. Relationship of oxygen radical-induced lipid peroxidative damage to disease onset and progression in a transgenic model of familial ALS.
Hall ED; Andrus PK; Oostveen JA; Fleck TJ; Gurney ME
J Neurosci Res; 1998 Jul; 53(1):66-77. PubMed ID: 9670993
[TBL] [Abstract][Full Text] [Related]
11. Inducible nitric oxide synthase up-regulation in a transgenic mouse model of familial amyotrophic lateral sclerosis.
Almer G; Vukosavic S; Romero N; Przedborski S
J Neurochem; 1999 Jun; 72(6):2415-25. PubMed ID: 10349851
[TBL] [Abstract][Full Text] [Related]
12. Age-dependent penetrance of disease in a transgenic mouse model of familial amyotrophic lateral sclerosis.
Chiu AY; Zhai P; Dal Canto MC; Peters TM; Kwon YW; Prattis SM; Gurney ME
Mol Cell Neurosci; 1995 Aug; 6(4):349-62. PubMed ID: 8846004
[TBL] [Abstract][Full Text] [Related]
13. Mutant mice, Cu,Zn superoxide dismutase, and motor neuron degeneration.
McCord JM
Science; 1994 Dec; 266(5190):1586-7. PubMed ID: 7985031
[No Abstract] [Full Text] [Related]
14. Transgenic mice carrying a human mutant superoxide dismutase transgene develop neuronal cytoskeletal pathology resembling human amyotrophic lateral sclerosis lesions.
Tu PH; Raju P; Robinson KA; Gurney ME; Trojanowski JQ; Lee VM
Proc Natl Acad Sci U S A; 1996 Apr; 93(7):3155-60. PubMed ID: 8610185
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional profiling in the lumbar spinal cord of a mouse model of amyotrophic lateral sclerosis: a role for wild-type superoxide dismutase 1 in sporadic disease?
D'Arrigo A; Colavito D; Peña-Altamira E; Fabris M; Dam M; Contestabile A; Leon A
J Mol Neurosci; 2010 Jul; 41(3):404-15. PubMed ID: 20177826
[TBL] [Abstract][Full Text] [Related]
16. Minute quantities of misfolded mutant superoxide dismutase-1 cause amyotrophic lateral sclerosis.
Jonsson PA; Ernhill K; Andersen PM; Bergemalm D; Brännström T; Gredal O; Nilsson P; Marklund SL
Brain; 2004 Jan; 127(Pt 1):73-88. PubMed ID: 14534160
[TBL] [Abstract][Full Text] [Related]
17. Transgenic mice expressing an altered murine superoxide dismutase gene provide an animal model of amyotrophic lateral sclerosis.
Ripps ME; Huntley GW; Hof PR; Morrison JH; Gordon JW
Proc Natl Acad Sci U S A; 1995 Jan; 92(3):689-93. PubMed ID: 7846037
[TBL] [Abstract][Full Text] [Related]
18. Protein oxidative damage in a transgenic mouse model of familial amyotrophic lateral sclerosis.
Andrus PK; Fleck TJ; Gurney ME; Hall ED
J Neurochem; 1998 Nov; 71(5):2041-8. PubMed ID: 9798929
[TBL] [Abstract][Full Text] [Related]
19. Lack of involvement of neuronal nitric oxide synthase in the pathogenesis of a transgenic mouse model of familial amyotrophic lateral sclerosis.
Facchinetti F; Sasaki M; Cutting FB; Zhai P; MacDonald JE; Reif D; Beal MF; Huang PL; Dawson TM; Gurney ME; Dawson VL
Neuroscience; 1999; 90(4):1483-92. PubMed ID: 10338314
[TBL] [Abstract][Full Text] [Related]
20. Bicarbonate enhances peroxidase activity of Cu,Zn-superoxide dismutase. Role of carbonate anion radical and scavenging of carbonate anion radical by metalloporphyrin antioxidant enzyme mimetics.
Zhang H; Joseph J; Gurney M; Becker D; Kalyanaraman B
J Biol Chem; 2002 Jan; 277(2):1013-20. PubMed ID: 11682485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
